Profile of BCR-ABL transcript levels based on Sokal prognostic score in chronic myeloid leukemia patients treated with imatinib

Tujuan: mengevaluasi pola dari respons molekular yang dinilai dengan reduksi kadar transkrip BCR-ABL berdasarkan skor prognosis sokal pada pasien leukemia mieloid kronis (LMK) fase kronis yang mendapat terapi Imatinib. Metode: penelitian dengan desain potong lintang dilakukan di Instalasi Rawat Jala...

Saved in:

書目詳細資料
Main Authors:	Ami Ashariati Prayoga, Siprianus Ugroseno Yudho Bintoro
格式:	Article PeerReviewed
語言:	English English English
出版:	The Indonesian Society of Internal medicine 2014
主題:	R Medicine (General) RC Internal medicine
在線閱讀:	http://repository.unair.ac.id/96200/1/Profil%20of%20BCR-ABL%20transcript.pdf http://repository.unair.ac.id/96200/2/Profil%20of%20BCR-ABL.pdf http://repository.unair.ac.id/96200/3/Profile%20of%20BCR-ABL%20transcript%20levels%20based%20on%20Sokal%20prognostic%20score%20in%20chronic%20myeloid%20leukemia%20patients%20treated%20with%20imatinib.pdf http://repository.unair.ac.id/96200/ http://www.inaactamedica.org/archives/2013/23770790.pdf
標簽:	添加標簽沒有標簽, 成為第一個標記此記錄!
機構:	Universitas Airlangga
語言:	English English English

相似書籍

Profile Of BCR-ABL Transcipt Levels Based on Sokal prognostic Score in Chronic Myeloid Leukimia Patients Treated With lmatinib
由: Ugroseno Yudho Bintoro, Siprianus
出版: (2013)

Correlation between Hasford Score with Early Molecular Response in Patients with Chronic Myeloid Leukemia in Chronic Phase Treated with Imatinib
由: I Dewa Made Widi Hersana, et al.
出版: (2019)

Relationship between trough level of tyrosine kinase inhibitor (imatinib and nilotinib) and BCR-ABL ratios in an Indonesian chronic-phase chronic myeloid leukemia (CML) population
由: Budi Suprapti, et al.
出版: (2020)

The Correlation of Imatinib Therapy Duration and Esti-mated Glomerular Filtration Rate in Chronic Myeloid Leukemia Patients
由: Siprianus Ugroseno Yudho Bintoro, et al.
出版: (2020)

Association between Hasford Scoring System and Hematologic Response in Chronic and Accelerated Phase of Chronic Myelocytic Leukemia Patient with Imatinib for Three Months
由: Andy Purnomo, et al.
出版: (2019)

Gene Mutation Profile in Chronic Myelogenous Leukemia BCR-ABL. Positive Chronic Phase Patients Which not Response to lmatinib Treatment in Dr. Soetomo Teaching Hospital Surabaya lndonesia
由: Ugroseno Yudho Bintoro, Siprianus
出版: (2014)

BCR-ABL Tyrosine Kinase Domain Mutations Combinations Affects Imat inib Resistence in Chronic Phase Chronic Myelogenous Leukemia
由: Siprianus Ugroseno Yudho Bintoro, et al.
出版: (2019)

Simvastatin enhances the efficacy of Bcr-Abl tyrosine kinase inhibitor nilotinib in chronic myeloid leukemia.
由: Koh, Yanqing.
出版: (2011)

Natural history of Southeast Asian chronic myeloid leukemia patients with different BCR-ABL gene variants
由: C. U. Auewarakul, et al.
出版: (2018)

Association between modified wells score and D-dimer in malignant lymphoma patients
由: Siprianus Ugroseno Yudho Bintoro, et al.
出版: (2018)

BIM Deletion Polymorphism Profiling Complements Prognostic Values of Risk Scores in Imatinib-treated Asian Chronic Myeloid Leukemia Patients
由: Hein Than, et al.
出版: (2019)

Impact of molecular response time achievement on survival of chronic phase chronic myelogenous leukemia patients treated by imatinib
由: Putu Niken Ayu Amrita, et al.
出版: (2020)

Chronic Myeloid Leukimia
由: Siprianus Ugroseno Yudho Bintoro
出版: (2019)

Pengaruh Mutasi JAK2 Positif Terhadap Respon Terapi HIDROKSIUREA pada Pasien Essential Trombosithemia (ET)
由: Siprianus Ugroseno Yudho Bintoro, et al.
出版: (2014)

BCR-ABL kinase domain mutations in tyrosine kinase inhibitors-naïve and -exposed Southeast Asian chronic myeloid leukemia patients
由: Wanwisa Wongboonma, et al.
出版: (2018)

A customized mass array panel for BCR::ABL1 tyrosine kinase domain mutation screening in chronic myeloid leukemia
由: Limsuwanachot N.
出版: (2023)

A rare e14a3 (b3a3) BCR-ABL fusion transcript in chronic myeloid leukemia: Diagnostic challenges in clinical laboratory practice
由: Natini Jinawath, et al.
出版: (2018)

Efficacy and safety of radotinib in chronic phase chronic myeloid leukemia patients with resistance or intolerance to BCR-ABL1 tyrosine kinase inhibitors
由: Sung Hyun Kim, et al.
出版: (2018)

The HDAC inhibitor SB939 overcomes resistance to BCR-ABL kinase Inhibitors conferred by the BIM deletion polymorphism in chronic myeloid leukemia
由: Rauzan M., et al.
出版: (2020)

Nilotinib versus imatinib for newly diagnosed chronic myeloid leukemia
由: Giuseppe Saglio, et al.
出版: (2018)

Chronic Myeloid Leukimia Perkembangan Baru Dalam Tata Laksana dan Implikasi Terhadap Ketahanan Hidup
由: Siprianus Ugroseno Yudho Bintoro
出版: (2019)

A Case Report of a Patient with a Rare and Aggressive Plasma Cell Leukemia
由: Siprianus Ugroseno Yudho Bintoro, et al.
出版: (2017)

Anti Rituximab antibody titer and therapeutic response in Non-Hodgkin Lymphoma Patient Receiving R-Chop Treatment
由: Roethmia Yaniari, et al.
出版: (2019)

Factors Related To The Survival Of Breast cancer patiens with positive expression of estrogen receptor receiving adjuvant antiestrogen therapy
由: Nisvi Dewi, et al.
出版: (2019)

C/EBPβ promotes BCR-ABL-mediated myeloid expansion and leukemic stem cell exhaustion
由: Hayashi, Y., et al.
出版: (2016)

Practical Laboratory Tools for Monitoring of BCR-ABL1 Transcripts and Tyrosine Kinase (TK) Domain Mutations in Chronic Myeloid Leukemia Patients Undergoing TK Inhibitor Therapy: A Single-Center Experience in Thailand
由: Nittaya Limsuwanachot, et al.
出版: (2020)

Detection of Molecular Variants of BCR-ABL Gene in Bone Marrow and Blood of Patients with Chronic Myeloid Leukemia by Reverse-Transcriptase Polymerase Chain Reaction (RT-PCR)
由: Chirayu Udomsakdi-Auewarakul, et al.
出版: (2018)

Pioglitazone together with imatinib in chronic myeloid leukemia: A proof of concept study
由: Philippe Rousselot, et al.
出版: (2018)

Allogeneic stem cell transplantation for patients harboring T315I BCR-ABL mutated leukemias
由: Nicolini, F.E., et al.
出版: (2016)

The pro-metastasis tyrosine phosphatase, PRL-3 (PTP4A3), is a novel mediator of oncogenic function of BCR-ABL in human chronic myeloid leukemia
由: Zhou J., et al.
出版: (2018)

The Effect of CHOP or RCHOP Chemotherapy Regiment on D-dimer Levels of Non-Hodgkin Lymphoma Patients
由: Dewi A.K., et al.
出版: (2019)

Hubungan antara Faktor Risiko Menurut Kriteria Lokal dengan Respon Terapi Hematologis Pasien CML di RSUD
由: Siprianus Ugroseno Yudho Bintoro, et al.
出版: (2017)

TARGETED COVALENT REVERSIBLE BCR-ABL INHIBITORS
由: DAVID QUACH THANH TRUONG
出版: (2020)

IN SILICO STUDY OF IODINATED 5,10,15,20-TETRAKIS(4-AMINOPHENYL) PORPHYRIN AS RADIOPHARMACEUTICALS CANDIDATE FOR CHRONIC MYELOID LEUKEMIA THERAPY AGAINST BCR-ABL1T315I
由: Kurniawan, Michael

ROLE OF BREAK CLUSTER REGION (BCR) - ABELSON MURINE LEUKIMIA (ABL) EXAMINATION IN CHRONIC MYELOGENOUS LEUKEMIA (CML)
由: Agung Sosiawan
出版: (2014)

Chromosomal aberrations and molecular changes in BCR-ABL gene in Chronic Myelogenous Leukemia (CML) patients undergoing chemotherapy
由: Soriano-Abad, Ma. Celeste S.
出版: (2010)

The Role Of JAK2 In Myeloproliferative Diseases Diagnosis
由: Yudith Annisa Ayu Rezkitha, et al.
出版: (2018)

คู่มือปฏิบัติงานการทดสอบ BCR-ABL gene
由: อรทัย พรหมสุวิชา
出版: (2016)

RESPONS HEMATOLOGI PENDERITA CHRONIC MYELOID LEUKEMIA SETELAH TERAPI IMATINIB DI RSUD DR. SOETOMO
由: KANYA CHATRA ADRIAVIRA, NIM011311133244
出版: (2017)

งานวิเคราะห์ เรื่อง การเปรียบเทียบผลการตรวจหาปริมาณยีน BCR-ABL p210 mRNA transcripts (%IS unit) ระหว่างชุดน้ำยา ipsogen® BCR-ABL1 Mbcr RGQ RT-PCR kit (Qiagen) กับชุดน้ำยา Xpert® BCR-ABL Ultra (Cepheid)
由: วรรณชัย ใสสะอาด, et al.
出版: (2022)